Literature DB >> 15797724

Opposing roles of ERK and p38 MAP kinases in FGF2-induced astroglial process extension.

Daniel S Heffron1, James W Mandell.   

Abstract

The stellate processes of astroglial cells undergo extensive remodeling in response to neural injury. Little is known about intracellular signaling mechanisms controlling process extension. We tested roles for the ERK and p38 MAP kinase pathways in a simplified culture model. FGF2-induced process extension was preceded by a strong and transient phosphorylation of ERK, and a modest activation of p38 MAP kinase, which exhibited significant basal activity. Phosphorylated ERK was found predominantly in the cytoplasm, whereas activated p38 MAP kinase was nuclear. Process extension was completely blocked by the specific MEK inhibitor U0126. Conversely, inhibition of the p38 MAP kinase pathway with SB202190 stimulated spontaneous process growth and greatly potentiated FGF2-induced process extension. The p38 inhibitor effect was reproduced with an adenovirus expressing dominant-negative p38 MAP kinase. Selective pharmacological blockade of MAP kinase pathways may enable modulation of the astroglial response to injury so as to promote neural regeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797724     DOI: 10.1016/j.mcn.2004.12.010

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  15 in total

1.  Brain-specific deletion of extracellular signal-regulated kinase 2 mitogen-activated protein kinase leads to aberrant cortical collagen deposition.

Authors:  Daniel S Heffron; Gary E Landreth; Ivy S Samuels; James W Mandell
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

2.  Isoflurane impairs immature astroglia development in vitro: the role of actin cytoskeleton.

Authors:  Nadia Lunardi; Christoph Hucklenbruch; Janelle R Latham; Joseph Scarpa; Vesna Jevtovic-Todorovic
Journal:  J Neuropathol Exp Neurol       Date:  2011-04       Impact factor: 3.685

3.  Brain-specific angiogenesis inhibitor-1 expression in astrocytes and neurons: implications for its dual function as an apoptotic engulfment receptor.

Authors:  Jennifer D Sokolowski; Suzanne L Nobles; Daniel S Heffron; Daeho Park; Kodi S Ravichandran; James W Mandell
Journal:  Brain Behav Immun       Date:  2010-10-01       Impact factor: 7.217

4.  The acute inhibition of enteric glial metabolism with fluoroacetate alters calcium signaling, hemichannel function, and the expression of key proteins.

Authors:  Jonathon L McClain; Brian D Gulbransen
Journal:  J Neurophysiol       Date:  2016-10-26       Impact factor: 2.714

5.  The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling.

Authors:  Siyun Liao; Darius Porter; Alana Scott; Gilbert Newman; Thomas Doetschman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2006-12-05       Impact factor: 5.000

Review 6.  Anti-fibrotic effects of pharmacologic FGF-2: a review of recent literature.

Authors:  David M Dolivo
Journal:  J Mol Med (Berl)       Date:  2022-04-28       Impact factor: 4.599

7.  SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons.

Authors:  Gavin Rumbaugh; J Paige Adams; Jee H Kim; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-14       Impact factor: 11.205

8.  BMP9 signaling in stem cell differentiation and osteogenesis.

Authors:  Joseph D Lamplot; Jiaqiang Qin; Guoxin Nan; Jinhua Wang; Xing Liu; Liangjun Yin; Justin Tomal; Ruidong Li; Wei Shui; Hongyu Zhang; Stephanie H Kim; Wenwen Zhang; Jiye Zhang; Yuhan Kong; Sahitya Denduluri; Mary Rose Rogers; Abdullah Pratt; Rex C Haydon; Hue H Luu; Jovito Angeles; Lewis L Shi; Tong-Chuan He
Journal:  Am J Stem Cells       Date:  2013-03-08

9.  Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.

Authors:  Arman Jahangiri; Michael De Lay; Liane M Miller; W Shawn Carbonell; Yu-Long Hu; Kan Lu; Maxwell W Tom; Jesse Paquette; Taku A Tokuyasu; Sean Tsao; Roxanne Marshall; Arie Perry; Kirsten M Bjorgan; Myriam M Chaumeil; Sabrina M Ronen; Gabriele Bergers; Manish K Aghi
Journal:  Clin Cancer Res       Date:  2013-01-10       Impact factor: 12.531

Review 10.  Fibroblast Growth Factor 2 as an Antifibrotic: Antagonism of Myofibroblast Differentiation and Suppression of Pro-Fibrotic Gene Expression.

Authors:  David M Dolivo; Sara A Larson; Tanja Dominko
Journal:  Cytokine Growth Factor Rev       Date:  2017-09-23       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.